CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and ChemotherapyJoel W. Neal, Thomas Newsom-Davis, Sang‐We Kim et al.|Journal of Clinical Oncology|2024Cited by 57
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerDaniel C. Christoph, Jeremias Wohlschlaeger|British Journal of Cancer|2012Cited by 35